Phoenix Biotech Acquisition Corp. Unit (PBAXU)

PBAXU was delisted on the 7th of February, 2024.

• Market cap: $190M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.